TRK Inhibitor AZD6918

Known as: AZD6918 
An orally available liquid suspension containing the tropomyosin receptor kinase (Trk) inhibitor AZD6918 with potential antineoplastic activity… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
01220112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Brain-derived neurotrophic factor (BDNF) is a potent neurotrophic factor that has been shown to stimulate breast cancer cell… (More)
Is this relevant?
2015
2015
TrkB activation by brain-derived neurotrophic factor (BDNF) contributes to chemo-resistance in neuroblastoma (NB). AZD6918 is a… (More)
Is this relevant?
2011
2011
PURPOSE TrkB has been involved in poor cancer outcome. TrkB mutations have been reported in non-small cell lung cancer. In this… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Purpose: TrkB has been involved in poor cancer outcome. TrkB mutations have been reported in non– small cell lung cancer. In this… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?